EUROPEAN COUNTRY. For a Drug Product comprising a Subsequent Compound that has received Marketing Authorization in the first European Country, Taisho shall provide Arena with an approval fee of [**********************************] within thirty (30) days of receipt of notification of such Marketing Authorization.
Appears in 1 contract
EUROPEAN COUNTRY. For a the first Drug Product comprising a Subsequent Compound that has received Marketing Authorization in the first European Country, Taisho shall provide Arena with an approval fee of [**********************************] within thirty (30) days of receipt of notification of such Marketing Authorization.
Appears in 1 contract
EUROPEAN COUNTRY. For a the first Drug Product comprising a Subsequent Compound that has received Marketing Authorization in the first European Country, Taisho shall provide Arena with an approval fee of [******************* (****************)] within thirty (30) days of receipt of notification of such Marketing Authorization.
Appears in 1 contract
Samples: Confidentiality Agreement (Arena Pharmaceuticals Inc)
EUROPEAN COUNTRY. For a Drug Product comprising a Subsequent Compound that has received Marketing Authorization in the first European Country, Taisho shall provide Arena with an approval fee of [******************** (***************)] within thirty (30) days of receipt of notification of such Marketing Authorization.
Appears in 1 contract
Samples: Confidentiality Agreement (Arena Pharmaceuticals Inc)